Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 28 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Simmons, Andrew [Clear All Filters]
Association of blood lipids with Alzheimer's disease: A comprehensive lipidomics analysis..
Alzheimers Dement. 13(2), 140-151.
(2017). The interactive effect of demographic and clinical factors on hippocampal volume: A multicohort study on 1958 cognitively normal individuals..
Hippocampus. 27(6), 653-667.
(2017). A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease..
J Alzheimers Dis. 56(3), 1159-1174.
(2017). Novel genetic loci associated with hippocampal volume..
Nat Commun. 8, 13624.
(2017). Disrupted Network Topology in Patients with Stable and Progressive Mild Cognitive Impairment and Alzheimer's Disease..
Cereb Cortex. 26(8), 3476-3493.
(2016). The effect of increased genetic risk for Alzheimer's disease on hippocampal and amygdala volume..
Neurobiol Aging. 40, 68-77.
(2016). Measuring Global Brain Atrophy with the Brain Volume/Cerebrospinal Fluid Index: Normative Values, Cut-Offs and Clinical Associations..
Neurodegener Dis. 16(1-2), 77-86.
(2016). Candidate blood proteome markers of Alzheimer's disease onset and progression: a systematic review and replication study..
J Alzheimers Dis. 38(3), 515-31.
(2014). Different multivariate techniques for automated classification of MRI data in Alzheimer's disease and mild cognitive impairment..
Psychiatry Res. 212(2), 89-98.
(2013). Entorhinal cortex thickness predicts cognitive decline in Alzheimer's disease..
J Alzheimers Dis. 33(3), 755-66.
(2013). Inflammatory proteins in plasma are associated with severity of Alzheimer's disease..
PLoS One. 8(6), e64971.
(2013). Education increases reserve against Alzheimer's disease--evidence from structural MRI analysis..
Neuroradiology. 54(9), 929-38.
(2012). Mitochondrial dysfunction and immune activation are detectable in early Alzheimer's disease blood..
J Alzheimers Dis. 30(3), 685-710.
(2012). Tocopherols and tocotrienols plasma levels are associated with cognitive impairment..
Neurobiol Aging. 33(10), 2282-90.
(2012). AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America..
Neuroimage. 58(3), 818-28.
(2011). The AddNeuroMed framework for multi-centre MRI assessment of Alzheimer's disease: experience from the first 24 months..
Int J Geriatr Psychiatry. 26(1), 75-82.
(2011). Automated hippocampal shape analysis predicts the onset of dementia in mild cognitive impairment..
Neuroimage. 56(1), 212-9.
(2011). Combination analysis of neuropsychological tests and structural MRI measures in differentiating AD, MCI and control groups--the AddNeuroMed study..
Neurobiol Aging. 32(7), 1198-206.
(2011). Combinatorial markers of mild cognitive impairment conversion to Alzheimer's disease--cytokines and MRI measures together predict disease progression..
J Alzheimers Dis. 26 Suppl 3, 395-405.
(2011). Multivariate analysis of MRI data for Alzheimer's disease, mild cognitive impairment and healthy controls..
Neuroimage. 54(2), 1178-87.
(2011). Plasma biomarkers of brain atrophy in Alzheimer's disease..
PLoS One. 6(12), e28527.
(2011).
(2011). Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimer's disease..
Neurobiol Aging. 31(8), 1375-85.
(2010). APOE ε2 allele is associated with larger regional cortical thicknesses and volumes..
Dement Geriatr Cogn Disord. 30(3), 229-37.
(2010). Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease..
Arch Gen Psychiatry. 67(7), 739-48.
(2010).